Public Health Action. 2014 Sep 21;4(3):159-63. doi: 10.5588/pha.14.0023.
Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji.
Public health action
P Prasad, S Gounder, S Varman, K Viney
Affiliations
Affiliations
- College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.
- National Tuberculosis Programme, Fiji Ministry of Health, Suva, Fiji.
- Public Health Division, Secretariat of the Pacific Community, Nouméa, New Caledonia ; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.
PMID: 26400803
PMCID: PMC4533811 DOI: 10.5588/pha.14.0023
Abstract
SETTINGS: Three tuberculosis (TB) treatment centres under the Fiji National Tuberculosis Programme.
OBJECTIVES: To determine the prevalence of diabetes mellitus (DM) among TB patients for the period 2010-2012, and to evaluate sputum smear conversion and anti-tuberculosis treatment outcomes, comparing patients with and without DM.
DESIGN: A retrospective descriptive study using routinely collected data from the TB register and in-patient folders.
RESULTS: Of 577 TB patients identified, information on DM was available for 567 (98%), of whom 68 (12%) had DM. Smear status at 2 months was available for 254 (82%) patients with sputum smear-positive pulmonary TB. The sputum smear conversion rate (from positive to negative) was equivalent in TB patients with and without DM (78% vs. 80%, P = 0.66). Anti-tuberculosis treatment outcome information was available for 462 patients; the difference in outcome comparing successfully treated patients with those unsuccessfully treated was not statistically significant (91% in TB patients with DM vs. 84% in TB patients without DM, P = 0.06).
CONCLUSION: DM is common among TB patients in Fiji. Sputum smear conversion rates were not different in TB patients with and without DM; no difference in treatment success between the two groups was observed.
Keywords: Fiji; diabetes mellitus; treatment outcomes; tuberculosis
References
- PLoS Med. 2008 Jul 15;5(7):e152 - PubMed
- Public Health Action. 2013 Nov 4;3(Suppl 1):S48-50 - PubMed
- Public Health Action. 2012 Dec 21;2(4):145-7 - PubMed
- PLoS One. 2012;7(7):e41367 - PubMed
- Int J Tuberc Lung Dis. 2001 May;5(5):455-61 - PubMed
- Int J Tuberc Lung Dis. 2011 Mar;15(3):337-43 - PubMed
- Chronic Illn. 2007 Sep;3(3):228-45 - PubMed
- PLoS One. 2011;6(8):e24215 - PubMed
- BMC Med. 2011 Jul 01;9:81 - PubMed
- Epidemiol Infect. 2009 Feb;137(2):203-10 - PubMed
- Am J Trop Med Hyg. 2009 Apr;80(4):634-9 - PubMed
- Int J Infect Dis. 2011 Dec;15(12):e818-21 - PubMed
- Int J Tuberc Lung Dis. 2006 Jun;10(6):696-700 - PubMed
- Thorax. 2013 Mar;68(3):214-20 - PubMed
- Public Health Action. 2013 Nov 4;3(Suppl 1):S38-42 - PubMed
- Bull World Health Organ. 2005 Jul;83(7):503-10 - PubMed
- J Formos Med Assoc. 2011 Jun;110(6):372-81 - PubMed
- Diabetes Res Clin Pract. 2012 Jun;96(3):385-91 - PubMed
- Clin Infect Dis. 2007 Aug 15;45(4):428-35 - PubMed
- Saudi Med J. 2003 Mar;24(3):278-81 - PubMed
Publication Types